J2351
HCPCSInj ocrelizumab 1mg hya-ocsq
Verified from hospital fileNot a bill estimate
iDirect answer
Based on the latest published hospital price files, code J2351 (Inj ocrelizumab 1mg hya-ocsq) appears at 4 hospitals with disclosed cash prices from $96,502 to $96,502. This is public hospital price transparency data, not a guaranteed estimate of your bill.
Published-price availability
3
hospitals publish a price
1
list this service without a published price
3
Cash
3
List
3
Negotiated
0
Allowed
A blank price (“—”) means a hospital names this service but did not publish a dollar amount — it is not a free service or a $0 price.
Compare J2351 prices
Filter by hospital, city, setting, or payer — the summary and charts update with your filters.
3
Hospitals
4
Prices shown
$96,502
Lowest cash
$96,502
Highest cash
code J2351 cash price3 disclosed · 3 hospitals
$96,502median ~$96,502$96,502
Lowest cash price by hospital
- Froedtert West Bend Hospital$96,502
Cash price by city
Reflects your current filters.
Cash price by city$96,502 – $96,502
- Menomonee Falls · 1 hospital$96,502
- West Bend · 1 hospital$96,502
- Manitowoc · 1 hospital$96,502
4 prices shown.
| Service | Hospital | Code | List price | Cash price | Negotiated range | Allowed (median) | |
|---|---|---|---|---|---|---|---|
| Inj ocrelizumab 1mg hya-ocsq Outpatient | University of Chicago Medical Center | J2351 HCPCS | — | — | — | — | |
| ocrelizumab-hyaluronidase-ocsq 920-23000 mg-unit/23 mL Solution 23 mL Vial Outpatient | Froedtert Menomonee Falls Hospital | J2351 HCPCS | $175,458 | $96,502 | $47.23 – $157,912 | — | |
| ocrelizumab-hyaluronidase-ocsq 920-23000 mg-unit/23 mL Solution 23 mL Vial Inpatient | Froedtert West Bend Hospital | J2351 HCPCS | $175,458 | $96,502 | $87,729 – $166,685 | — | |
| ocrelizumab-hyaluronidase-ocsq 920-23000 mg-unit/23 mL Solution 23 mL Vial Inpatient | Froedtert Holy Family Memorial Hospital | J2351 HCPCS | $175,458 | $96,502 | $87,729 – $154,403 | — |
How to read these prices
- Cash price
- The discounted self-pay price for paying directly, without insurance.
- List price
- The hospital’s full undiscounted charge — rarely what anyone pays.
- Negotiated rate
- A rate for a specific insurer and plan; your share depends on your benefits.
- Allowed amount
- A historical reference for what was actually allowed, where disclosed.
Hospitals that publish J2351 prices
Open a hospital to see this code in the context of its full published prices.
Code J2351: frequently asked
- What does code J2351 cost?
- Across the published hospital price files, the disclosed cash price for J2351 ranges from $96,502 to $96,502. This is public hospital price transparency data, not a guaranteed estimate of your bill.
- Will this be my final bill?
- Actual patient responsibility may vary based on your insurance plan, deductible, coinsurance, network status, diagnosis, setting, bundled services, clinical circumstances, and hospital billing practices.
- What is code J2351?
- J2351 is the billing code hospitals use to identify "Inj ocrelizumab 1mg hya-ocsq" on their published price files. We use it to line up the same service across different hospitals.
- Why do prices for this code differ between hospitals?
- Each hospital sets its own prices and negotiates separately with each insurer, so the disclosed price for the same code can vary widely from one hospital to another — and even between plans at a single hospital. Comparing the published figures is what this page is for; a difference does not by itself mean one hospital is better or worse.
- What this page is not
- It is not a quote, a guarantee, or medical advice. It shows what hospitals have published for this code, so you can compare and ask informed questions — your actual cost depends on your insurance, the exact services performed, and the care setting.